← Leaderboards
Prabhani Atukorale
University Of Massachusetts Amherst
$1,219,778
Attributed
$1,219,778
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $431.8K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,219,778 · 2
By mechanism
R21$636,856 · 1
K22$582,922 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Massachusetts Amherst
Same institution · by research overlap
- Ashish A. Kulkarni$2,082,860
- Sian L Gramates$5,140
- Ashish Kulkarni$637,359
Others in their field
Other Emerging Leaders on “Macrophage”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Frederic Geissmann · Sloan-Kettering Inst Can Research$12,957,901
- Adam David Hoppe · South Dakota State University$9,046,059
- Niccolo Terrando · Duke University$6,839,733
- Markus Bosmann · Boston University Medical Campus$6,657,387
- Benson Edagwa · University Of Nebraska Medical Center$6,144,379
Research focus
MacrophageLymph NodesEncapsulatedIn VitroKineticsLipidsCytokineDesignInterferon Type IInnovationIn VivoAntigen-Presenting CellsAgonistLipid ABlood CirculationCellsDendritic CellsDepositionImmuneEngineering DesignImmunosuppressionInflammatoryAutomobile DrivingMalignant Neoplasms
Grant awards (6)
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination$200,126
R21 · FY2025 · EB · contact PI
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination$198,981
R21 · FY2024 · EB · contact PI
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination$237,749
R21 · FY2023 · EB · contact PI
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination$194,090
K22 · FY2023 · CA · contact PI
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination$194,308
K22 · FY2022 · CA · contact PI
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination$194,524
K22 · FY2021 · CA · contact PI